Similar Search Results

Do faster food and drug administration drug reviews adversely affect patient safety? : an analysis of the 1992 prescription Drug User Fee Act

Grabowski, Henry G.; Wang, Yng-Yuh Richard - In: The journal of law & economics 51 (2008) 2, pp. 377-406

Persistent link: https://www.econbiz.de/10003762540

Patents, innovation and access to new pharmaceuticals

Grabowski, Henry G. - In: Journal of international economic law 5 (2002) 4, pp. 849-860

Persistent link: https://www.econbiz.de/10001722195

Competition between generic and branded drugs

Grabowski, Henry G. - In: Pharmaceutical innovation : incentives, competition, …, (pp. 153-173). 2007

Persistent link: https://www.econbiz.de/10003498977

Increasing R&D incentives for neglected diseases : lessons from the Orphan Drug Act

Grabowski, Henry - In: International public goods and transfer of technology …, (pp. 425-456). 2005

Persistent link: https://www.econbiz.de/10003414416

Health reform and pharmaceutical innovation

Grabowski, Henry G. - 1994

Persistent link: https://www.econbiz.de/10013538447

The impact of price regulation on the launch delay of new drugs : evidence from twenty-five major markets in the 1990s

Danzon, Patricia Munch; Wang, Yng-Yuh Richard; Wang, Liang - 2003

Persistent link: https://www.econbiz.de/10001785484

The impact of price regulation on the launch delay of new drugs : evidence from twenty-five major markets in the 1990s

Danzon, Patricia Munch; Wang, Yng-Yuh Richard; Wang, Liang - In: Health economics 14 (2005) 3, pp. 269-292

Persistent link: https://www.econbiz.de/10002709522

Spillover effects of restrictive drug formularies on physician prescribring behavior : evidence from Medicaid

Wang, Yng-Yuh Richard; Pauly, Mark V. - In: Journal of economics & management strategy : JEMS 14 (2005) 3, pp. 755-773

Persistent link: https://www.econbiz.de/10003094157

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

Danzon, Patricia Munch - 2003

This study analyzes the effect of pharmaceutical price regulation on delays in new drug launches. Because low price in one market may 'spill-over' to others, though parallel trade and external referencing, manufacturers may rationally prefer longer delay or non-launch to accepting a low price....

Persistent link: https://www.econbiz.de/10012468823

The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s

Danzon, Patricia M.; Wang, Y. Richard; Wang, Liang Leon - 2021

Persistent link: https://www.econbiz.de/10013222052